Compare LNTH & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNTH | VFS |
|---|---|---|
| Founded | 1956 | 2017 |
| Country | United States | Vietnam |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 7.3B |
| IPO Year | 2014 | 2022 |
| Metric | LNTH | VFS |
|---|---|---|
| Price | $100.62 | $3.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $87.00 | $5.83 |
| AVG Volume (30 Days) | ★ 1.1M | 292.5K |
| Earning Date | 05-07-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.91 | N/A |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | $70.58 |
| Revenue Next Year | $14.19 | N/A |
| P/E Ratio | $34.60 | ★ N/A |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $49.67 | $2.78 |
| 52 Week High | $111.86 | $5.29 |
| Indicator | LNTH | VFS |
|---|---|---|
| Relative Strength Index (RSI) | 45.87 | 44.75 |
| Support Level | $100.51 | $2.96 |
| Resistance Level | $101.43 | $3.26 |
| Average True Range (ATR) | 0.51 | 0.08 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 43.84 | 9.09 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.